$TTOO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in T2 Biosystems, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in T2 Biosystems, Inc.. Get notifications about new insider transactions in T2 Biosystems, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 18 2021 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | Chief Operations Of ... | Sell | S | 1.86 | 12,494 | 23,239 | 74,420 | 86.9 K to 74.4 K (-14.38 %) |
Mar 18 2021 | TTOO | T2 Biosystems, Inc ... | Pare Anthony | Chief Commercial Of ... | Sell | S | 1.84 | 9,620 | 17,701 | 31,612 | 41.2 K to 31.6 K (-23.33 %) |
Mar 16 2021 | TTOO | T2 Biosystems, Inc ... | Pare Anthony | Chief Commercial Of ... | Option Exercise | M | 0.00 | 17,500 | 0 | 35,000 | |
Mar 16 2021 | TTOO | T2 Biosystems, Inc ... | Pare Anthony | Chief Commercial Of ... | Buy | M | 0.00 | 17,500 | 0 | 41,232 | 23.7 K to 41.2 K (+73.74 %) |
Mar 16 2021 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | Chief Operations Of ... | Option Exercise | M | 0.00 | 21,667 | 0 | 43,333 | |
Mar 16 2021 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | Chief Operations Of ... | Buy | M | 0.00 | 21,667 | 0 | 86,914 | 65.2 K to 86.9 K (+33.21 %) |
Feb 26 2021 | TTOO | T2 Biosystems, Inc ... | Pare Anthony | Chief Commercial Of ... | Option Exercise | A | 0.00 | 505,464 | 0 | 505,464 | |
Feb 26 2021 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | Chief Operations Of ... | Option Exercise | A | 0.00 | 505,464 | 0 | 505,464 | |
Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Sell | S | 2.06 | 7,280 | 14,997 | 65,347 | 72.6 K to 65.3 K (-10.02 %) |
Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Buy | M | 0.00 | 10,000 | 0 | 72,627 | 62.6 K to 72.6 K (+15.97 %) |
Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Sprague John M | Chief Financial Off ... | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Sprague John M | Chief Financial Off ... | Sell | S | 2.04 | 5,250 | 10,710 | 35,485 | 40.7 K to 35.5 K (-12.89 %) |
Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Sprague John M | Chief Financial Off ... | Buy | M | 0.00 | 10,000 | 0 | 40,735 | 30.7 K to 40.7 K (+32.54 %) |
Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | Chief Operations Of ... | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | Chief Operations Of ... | Sell | S | 2.06 | 7,280 | 14,997 | 65,247 | 72.5 K to 65.2 K (-10.04 %) |
Feb 23 2021 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | Chief Operations Of ... | Buy | M | 0.00 | 10,000 | 0 | 72,527 | 62.5 K to 72.5 K (+15.99 %) |
Jan 19 2021 | TTOO | T2 Biosystems, Inc ... | Ahuja Aparna | Chief Medical Offic ... | Option Exercise | A | 0.00 | 460,992 | 0 | 460,992 | |
Jan 05 2021 | TTOO | T2 Biosystems, Inc ... | Bernard Thierry | Director | Option Exercise | A | 0.00 | 32,258 | 0 | 32,258 | |
Jan 05 2021 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Option Exercise | M | 0.00 | 34,188 | 0 | 34,188 | |
Jan 05 2021 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Option Exercise | A | 0.00 | 32,258 | 0 | 32,258 | |
Jan 05 2021 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Buy | M | 0.00 | 34,188 | 0 | 84,185 | 50 K to 84.2 K (+68.38 %) |
Jan 05 2021 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | M | 0.00 | 34,188 | 0 | 34,188 | |
Jan 05 2021 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | A | 0.00 | 32,258 | 0 | 32,258 | |
Jan 05 2021 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Buy | M | 0.00 | 34,188 | 0 | 125,269 | 91.1 K to 125.3 K (+37.54 %) |
Jan 05 2021 | TTOO | T2 Biosystems, Inc ... | Toft Robin | Director | Option Exercise | A | 0.00 | 32,258 | 0 | 32,258 | |
Jan 05 2021 | TTOO | T2 Biosystems, Inc ... | Saunders Ninfa | Director | Option Exercise | A | 0.00 | 32,258 | 0 | 32,258 | |
Aug 07 2020 | TTOO | T2 Biosystems, Inc ... | McDonough John | Director | Option Exercise | A | 0.00 | 45,454 | 0 | 45,454 | |
Aug 07 2020 | TTOO | T2 Biosystems, Inc ... | CUMMING JOHN W | Director | Option Exercise | A | 0.00 | 45,454 | 0 | 45,454 | |
Aug 07 2020 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Option Exercise | A | 0.00 | 45,454 | 0 | 45,454 | |
Aug 07 2020 | TTOO | T2 Biosystems, Inc ... | Toft Robin | Director | Option Exercise | A | 0.00 | 68,181 | 0 | 68,181 | |
Aug 07 2020 | TTOO | T2 Biosystems, Inc ... | Saunders Ninfa | Director | Option Exercise | A | 0.00 | 68,181 | 0 | 68,181 | |
Aug 07 2020 | TTOO | T2 Biosystems, Inc ... | Bernard Thierry | Director | Option Exercise | A | 0.00 | 68,181 | 0 | 68,181 | |
Aug 07 2020 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | A | 0.00 | 45,454 | 0 | 45,454 | |
Mar 26 2020 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Mar 26 2020 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Option Exercise | A | 0.39 | 100,000 | 39,000 | 100,000 | |
Mar 18 2020 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Option Exercise | A | 0.00 | 65,000 | 0 | 65,000 | |
Mar 18 2020 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Option Exercise | A | 0.40 | 130,000 | 51,350 | 130,000 | |
Mar 18 2020 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | A | 0.00 | 90,000 | 0 | 90,000 | |
Mar 18 2020 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | A | 0.40 | 180,000 | 71,100 | 180,000 | |
Mar 18 2020 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Option Exercise | A | 0.00 | 65,000 | 0 | 65,000 | |
Mar 18 2020 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Option Exercise | A | 0.40 | 130,000 | 51,350 | 130,000 | |
Mar 18 2020 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | A | 0.00 | 90,000 | 0 | 90,000 | |
Mar 18 2020 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | A | 0.40 | 180,000 | 71,100 | 180,000 | |
Mar 18 2020 | TTOO | T2 Biosystems, Inc ... | Pare Anthony | Chief Commercial Of ... | Option Exercise | A | 0.00 | 52,500 | 0 | 52,500 | |
Mar 18 2020 | TTOO | T2 Biosystems, Inc ... | Pare Anthony | Chief Commercial Of ... | Option Exercise | A | 0.40 | 105,000 | 41,475 | 105,000 | |
Mar 03 2020 | TTOO | T2 Biosystems, Inc ... | Sprague John M | Chief Financial Off ... | Option Exercise | M | 0.00 | 10,000 | 0 | 20,000 | |
Mar 03 2020 | TTOO | T2 Biosystems, Inc ... | Sprague John M | Chief Financial Off ... | Sell | S | 0.82 | 4,166 | 3,416 | 22,222 | 26.4 K to 22.2 K (-15.79 %) |
Mar 03 2020 | TTOO | T2 Biosystems, Inc ... | Sprague John M | Chief Financial Off ... | Buy | M | 0.00 | 10,000 | 0 | 26,388 | 16.4 K to 26.4 K (+61.02 %) |
Feb 25 2020 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Option Exercise | M | 0.00 | 10,000 | 0 | 20,000 | |
Feb 25 2020 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Sell | S | 0.82 | 5,808 | 4,763 | 46,294 | 52.1 K to 46.3 K (-11.15 %) |
Feb 25 2020 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Buy | M | 0.00 | 10,000 | 0 | 52,102 | 42.1 K to 52.1 K (+23.75 %) |
Feb 25 2020 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Option Exercise | M | 0.00 | 10,000 | 0 | 20,000 | |
Feb 25 2020 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Sell | S | 0.82 | 5,808 | 4,763 | 60,779 | 66.6 K to 60.8 K (-8.72 %) |
Feb 25 2020 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Buy | M | 0.00 | 10,000 | 0 | 66,587 | 56.6 K to 66.6 K (+17.67 %) |
Feb 25 2020 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 0.00 | 10,000 | 0 | 20,000 | |
Feb 25 2020 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Sell | S | 0.82 | 5,808 | 4,763 | 68,994 | 74.8 K to 69 K (-7.76 %) |
Feb 25 2020 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 0.00 | 10,000 | 0 | 74,802 | 64.8 K to 74.8 K (+15.43 %) |
Feb 12 2020 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 0.00 | 5,833 | 0 | 0 | |
Feb 12 2020 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Sell | S | 0.77 | 3,200 | 2,464 | 64,802 | 68 K to 64.8 K (-4.71 %) |
Feb 12 2020 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 0.00 | 5,833 | 0 | 68,002 | 62.2 K to 68 K (+9.38 %) |
Feb 12 2020 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Option Exercise | M | 0.00 | 5,833 | 0 | 0 | |
Feb 12 2020 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Sell | S | 0.77 | 3,200 | 2,464 | 56,587 | 59.8 K to 56.6 K (-5.35 %) |
Feb 12 2020 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Buy | M | 0.00 | 5,833 | 0 | 59,787 | 54 K to 59.8 K (+10.81 %) |
Feb 05 2020 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Sell | S | 0.88 | 3,283 | 2,889 | 53,954 | 57.2 K to 54 K (-5.74 %) |
Feb 05 2020 | TTOO | T2 Biosystems, Inc ... | McDonough John | Director | Sell | S | 0.88 | 23,754 | 20,904 | 489,114 | 512.9 K to 489.1 K (-4.63 %) |
Feb 05 2020 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Sell | S | 0.88 | 7,535 | 6,631 | 62,169 | 69.7 K to 62.2 K (-10.81 %) |
Jan 27 2020 | TTOO | T2 Biosystems, Inc ... | McDonough John | Director | Sell | S | 1.15 | 57,417 | 66,030 | 512,868 | 570.3 K to 512.9 K (-10.07 %) |
Jan 10 2020 | TTOO | T2 Biosystems, Inc ... | McDonough John | Director | Option Exercise | M | 0.00 | 100,000 | 0 | 0 | |
Jan 10 2020 | TTOO | T2 Biosystems, Inc ... | McDonough John | Director | Option Exercise | M | 0.00 | 16,666 | 0 | 0 | |
Jan 10 2020 | TTOO | T2 Biosystems, Inc ... | McDonough John | Director | Option Exercise | D | 0.00 | 326,087 | 0 | 0 | |
Jan 10 2020 | TTOO | T2 Biosystems, Inc ... | McDonough John | Director | Buy | M | 0.00 | 100,000 | 0 | 570,285 | 470.3 K to 570.3 K (+21.26 %) |
Jan 10 2020 | TTOO | T2 Biosystems, Inc ... | McDonough John | Director | Buy | M | 0.00 | 16,666 | 0 | 470,285 | 453.6 K to 470.3 K (+3.67 %) |
Jan 10 2020 | TTOO | T2 Biosystems, Inc ... | McDonough John | Director | Option Exercise | M | 0.00 | 100,000 | 0 | 0 | |
Jan 10 2020 | TTOO | T2 Biosystems, Inc ... | McDonough John | Director | Option Exercise | M | 0.00 | 16,666 | 0 | 0 | |
Jan 10 2020 | TTOO | T2 Biosystems, Inc ... | McDonough John | Director | Option Exercise | D | 0.00 | 326,087 | 0 | 0 | |
Jan 10 2020 | TTOO | T2 Biosystems, Inc ... | McDonough John | Director | Buy | M | 0.00 | 100,000 | 0 | 570,285 | 470.3 K to 570.3 K (+21.26 %) |
Jan 10 2020 | TTOO | T2 Biosystems, Inc ... | McDonough John | Director | Buy | M | 0.00 | 16,666 | 0 | 470,285 | 453.6 K to 470.3 K (+3.67 %) |
Jan 07 2020 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Sell | S | 1.16 | 5,316 | 6,167 | 91,081 | 96.4 K to 91.1 K (-5.51 %) |
Jan 06 2020 | TTOO | T2 Biosystems, Inc ... | GOLDMAN SACHS GROUP INC | Grant | A | 0.00 | 34,188 | 0 | 4,270,641 | 4.2 M to 4.3 M (+0.81 %) | |
Jan 06 2020 | TTOO | T2 Biosystems, Inc ... | Jones Adrian M | Grant | A | 0.00 | 34,188 | 0 | 4,270,641 | 4.2 M to 4.3 M (+0.81 %) | |
Jan 03 2020 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Option Exercise | M | 0.00 | 13,289 | 0 | 13,289 | |
Jan 03 2020 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Option Exercise | A | 0.00 | 34,188 | 0 | 34,188 | |
Jan 03 2020 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Buy | M | 0.00 | 13,289 | 0 | 50 | -13,239 to 50 (-100.38 %) |
Jan 03 2020 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | M | 0.00 | 13,289 | 0 | 13,289 | |
Jan 03 2020 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | A | 0.00 | 34,188 | 0 | 34,188 | |
Jan 03 2020 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Buy | M | 0.00 | 13,289 | 0 | 96,397 | 83.1 K to 96.4 K (+15.99 %) |
Jan 03 2020 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | M | 0.00 | 13,289 | 0 | 13,289 | |
Jan 03 2020 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | A | 0.00 | 34,188 | 0 | 34,188 | |
Jan 03 2020 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Buy | M | 0.00 | 13,289 | 0 | 96,397 | 83.1 K to 96.4 K (+15.99 %) |
Sep 13 2019 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Option Exercise | A | 1.43 | 200,000 | 286,000 | 200,000 | |
Sep 13 2019 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Sell | S | 2.92 | 4,210 | 12,293 | 42,102 | 46.3 K to 42.1 K (-9.09 %) |
Sep 13 2019 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Buy | M | 0.00 | 10,000 | 0 | 46,312 | 36.3 K to 46.3 K (+27.54 %) |
Sep 12 2019 | TTOO | T2 Biosystems, Inc ... | Sprague John M | Chief Financial Off ... | Option Exercise | A | 1.43 | 50,000 | 71,500 | 50,000 | |
Sep 12 2019 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Option Exercise | A | 1.43 | 50,000 | 71,500 | 50,000 | |
Sep 12 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | A | 1.43 | 100,000 | 143,000 | 100,000 | |
Jun 13 2019 | TTOO | T2 Biosystems, Inc ... | Cima Michael J. | Director | Sell | S | 1.43 | 3,240 | 4,633 | 213,178 | 216.4 K to 213.2 K (-1.50 %) |
Jun 13 2019 | TTOO | T2 Biosystems, Inc ... | Lapidus Stanley | Director | Sell | S | 1.44 | 9,000 | 12,960 | 53,010 | 62 K to 53 K (-14.51 %) |
Jun 13 2019 | TTOO | T2 Biosystems, Inc ... | CUMMING JOHN W | Director | Sell | S | 1.43 | 3,420 | 4,891 | 23,580 | 27 K to 23.6 K (-12.67 %) |
Jun 13 2019 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Sell | S | 1.44 | 3,600 | 5,184 | 83,108 | 86.7 K to 83.1 K (-4.15 %) |
Jun 12 2019 | TTOO | T2 Biosystems, Inc ... | Jones Adrian M | Option Exercise | A | 1.54 | 22,000 | 33,880 | 22,000 | ||
Jun 11 2019 | TTOO | T2 Biosystems, Inc ... | Lapidus Stanley | Director | Option Exercise | A | 1.54 | 22,000 | 33,880 | 22,000 | |
Jun 11 2019 | TTOO | T2 Biosystems, Inc ... | Lapidus Stanley | Director | Option Exercise | M | 0.00 | 9,000 | 0 | 9,000 | |
Jun 11 2019 | TTOO | T2 Biosystems, Inc ... | Lapidus Stanley | Director | Buy | M | 0.00 | 9,000 | 0 | 62,010 | 53 K to 62 K (+16.98 %) |
Jun 11 2019 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | A | 1.54 | 22,000 | 33,880 | 22,000 | |
Jun 11 2019 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | M | 0.00 | 9,000 | 0 | 9,000 | |
Jun 11 2019 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Buy | M | 0.00 | 9,000 | 0 | 86,708 | 77.7 K to 86.7 K (+11.58 %) |
Jun 11 2019 | TTOO | T2 Biosystems, Inc ... | CUMMING JOHN W | Director | Option Exercise | A | 1.54 | 22,000 | 33,880 | 22,000 | |
Jun 11 2019 | TTOO | T2 Biosystems, Inc ... | CUMMING JOHN W | Director | Option Exercise | M | 0.00 | 9,000 | 0 | 9,000 | |
Jun 11 2019 | TTOO | T2 Biosystems, Inc ... | CUMMING JOHN W | Director | Buy | M | 0.00 | 9,000 | 0 | 27,000 | 18 K to 27 K (+50.00 %) |
Jun 11 2019 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Option Exercise | A | 1.54 | 22,000 | 33,880 | 22,000 | |
Jun 11 2019 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Option Exercise | M | 0.00 | 9,000 | 0 | 9,000 | |
Jun 11 2019 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Buy | M | 0.00 | 9,000 | 0 | 36,708 | 27.7 K to 36.7 K (+32.48 %) |
Jun 11 2019 | TTOO | T2 Biosystems, Inc ... | Cima Michael J. | Director | Option Exercise | A | 1.54 | 22,000 | 33,880 | 22,000 | |
Jun 11 2019 | TTOO | T2 Biosystems, Inc ... | Cima Michael J. | Director | Option Exercise | M | 0.00 | 9,000 | 0 | 9,000 | |
Jun 11 2019 | TTOO | T2 Biosystems, Inc ... | Cima Michael J. | Director | Buy | M | 0.00 | 9,000 | 0 | 216,418 | 207.4 K to 216.4 K (+4.34 %) |
Feb 25 2019 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Feb 25 2019 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Option Exercise | A | 3.72 | 60,000 | 223,200 | 60,000 | |
Feb 25 2019 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Feb 25 2019 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Option Exercise | A | 3.72 | 200,000 | 744,000 | 200,000 | |
Feb 25 2019 | TTOO | T2 Biosystems, Inc ... | Sprague John M | Chief Financial Off ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Feb 25 2019 | TTOO | T2 Biosystems, Inc ... | Sprague John M | Chief Financial Off ... | Option Exercise | A | 3.72 | 60,000 | 223,200 | 60,000 | |
Feb 25 2019 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Feb 25 2019 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Option Exercise | A | 3.72 | 60,000 | 223,200 | 60,000 | |
Feb 25 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Feb 25 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | A | 3.72 | 60,000 | 223,200 | 60,000 | |
Feb 12 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 0.00 | 5,834 | 0 | 5,833 | |
Feb 12 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Sell | S | 3.36 | 3,005 | 10,097 | 69,704 | 72.7 K to 69.7 K (-4.13 %) |
Feb 12 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 0.00 | 5,834 | 0 | 72,709 | 66.9 K to 72.7 K (+8.72 %) |
Feb 12 2019 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Option Exercise | M | 0.00 | 5,834 | 0 | 5,833 | |
Feb 12 2019 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Sell | S | 3.36 | 3,005 | 10,097 | 57,237 | 60.2 K to 57.2 K (-4.99 %) |
Feb 12 2019 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Buy | M | 0.00 | 5,834 | 0 | 60,262 | 54.4 K to 60.3 K (+10.72 %) |
Feb 12 2019 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Option Exercise | M | 0.00 | 16,666 | 0 | 16,667 | |
Feb 12 2019 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Sell | S | 3.36 | 8,134 | 27,330 | 448,220 | 456.4 K to 448.2 K (-1.78 %) |
Feb 12 2019 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Buy | M | 0.00 | 16,666 | 0 | 456,354 | 439.7 K to 456.4 K (+3.79 %) |
Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Option Exercise | M | 0.00 | 6,500 | 0 | 0 | |
Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Option Exercise | M | 0.00 | 6,500 | 0 | 0 | |
Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Sell | S | 3.47 | 1,820 | 6,315 | 54,428 | 56.2 K to 54.4 K (-3.24 %) |
Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Sell | S | 3.35 | 939 | 3,146 | 56,248 | 57.2 K to 56.2 K (-1.64 %) |
Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Buy | M | 0.00 | 6,500 | 0 | 57,187 | 50.7 K to 57.2 K (+12.82 %) |
Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Buy | M | 0.00 | 6,500 | 0 | 50,687 | 44.2 K to 50.7 K (+14.71 %) |
Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Option Exercise | M | 0.00 | 47,422 | 0 | 0 | |
Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Option Exercise | M | 0.00 | 47,423 | 0 | 0 | |
Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Sell | S | 3.47 | 9,443 | 32,767 | 439,688 | 449.1 K to 439.7 K (-2.10 %) |
Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Sell | S | 3.35 | 4,895 | 16,398 | 449,131 | 454 K to 449.1 K (-1.08 %) |
Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Buy | M | 0.00 | 47,422 | 0 | 454,026 | 406.6 K to 454 K (+11.66 %) |
Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Buy | M | 0.00 | 47,423 | 0 | 406,604 | 359.2 K to 406.6 K (+13.20 %) |
Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 |